$LCTX News

Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell Therapeutics Q2 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. Q2 2026 Earnings Call Summary

Lineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ...

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2026 Earnings Call Transcript

Lineage Cell Therapeutics (NYSEARCA:LCTX) Slips on Q2 Revenue Miss, but EPS In Line and Pipeline Advances

Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates

Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject’ Cell Therapy Plan

Lineage Cell Therapeutics, Inc. (LCTX) Discusses COR1 Cell Transplant Program and Manufacturing Strategy for Corneal Endothelial Disease Transcript

Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

Lineage Cell Therapeutics Updates COR1 Corneal Cell Transplant Program; Highlights Scalable Allogeneic Production Via AlloSCOPE Platform And Plans Conference Call Today

Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit

Transcript: Lineage Cell Therapeutics Q1 2026 Earnings Conference Call

Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage

How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets

Lineage Cell Therapeutics Q1 Earnings Call Highlights

Lineage Cell Therapeutics, Inc. Q1 2026 Earnings Call Summary

Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highlights: Strategic Advances and ...